Manipal Acunova Limited, a contract research organization, provides a range of services to biotechnology, pharmaceutical, device, diagnostic and nutrition, generic drug, and regenerative medicine industries in the United States, Europe, Japan, India, China, Canada, Israel, and internationally. It offers biosimilars development, cell therapy, and diagnostic imaging agent development services; bioavailability and bioequivalence services; Phase II-IV clinical trials management services; clinical data management, biostatistics, and medical writing services; regulatory affairs; pharmacovigilance processes; central laboratory testing services for clinical trials; strategic consulting; non-interventional studies; early development of PhI, BA/BE, PK/PD; and various therapeutic services. The ethos of the company was described through a new concept each year which was applied across all marketing materials.